Filtered By:
Drug: Tamiflu

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 286 results found since Jan 2013.

Coronavirus: Ten Reasons Why You Ought Not to Panic
This article is republished from The Conversation. Read the original article. The post Coronavirus: Ten Reasons Why You Ought Not to Panic appeared first on Inter Press Service. Excerpt: Ignacio López-Goñi is microbiologist and works in University of Navarra (Spain). The post Coronavirus: Ten Reasons Why You Ought Not to Panic appeared first on Inter Press Service.
Source: IPS Inter Press Service - Health - March 7, 2020 Category: International Medicine & Public Health Authors: Ignacio Lopez Goni Tags: Global Headlines Health Coronavirus Source Type: news

Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018.
CONCLUSION: Primary care patients with ILI testing positive for coronavirus (not including SARS-CoV-2) recovered sooner when oseltamivir was added to usual care compared with usual care alone. This may be of relevance to the primary care management of COVID-19. PMID: 32571773 [PubMed - as supplied by publisher]
Source: The British Journal of General Practice - June 21, 2020 Category: Primary Care Authors: Coenen S, van der Velden AW, Cianci D, Goossens H, Bongard E, Saville BR, Gobat N, de Paor M, Ieven M, Verheij TJ, Butler CC Tags: Br J Gen Pract Source Type: research

SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus.
Abstract Here we report on the most recent updates on experimental drugs successfully employed in the treatment of the disease caused by SARS CoV-2 coronavirus, also referred to as COVID-19 (COronaVIrus Disease 19). In particular, several cases of recovered patients have been reported after being treated with lopinavir/ritonavir (which is widely used to treat human immunodeficiency virus (HIV) infection) in combination with the anti-flu drug oseltamivir. In addition, remdesivir, which has been previously administered to Ebola virus patients, has also proven effective in the U.S. against coronavirus, while antimala...
Source: Current Medicinal Chemistry - April 15, 2020 Category: Chemistry Authors: Costanzo M, De Giglio MAR, Roviello GN Tags: Curr Med Chem Source Type: research

Influenza A virus exposure may cause increased symptom severity and deaths in coronavirus disease 2019.
CONCLUSIONS: The study suggests that during the flu season, close attention should be paid to the probability of IAV exposure in COVID-19 patients. Prospective studies with larger sample sizes are needed to clarify whether IAV increases the fatality rate of COVID-19 and to elucidate any benefits of empirical usage of oseltamivir. PMID: 32842015 [PubMed - as supplied by publisher]
Source: Chinese Medical Journal - August 23, 2020 Category: General Medicine Authors: Hu ZW, Wang X, Zhao JP, Ma J, Li HC, Wang GF, Cheng Y, Zhang H Tags: Chin Med J (Engl) Source Type: research

Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report.
Abstract Since December 2019, there has been an increasing number of patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) around the world. As of March 2020, the World Health Organization declared a global pandemic. To our best knowledge, this is the first report of a patient with SARS-CoV-2 infection presenting with constrictive pericarditis, possibly from the COVID infection. She was presented after a week of fever, persistent dry cough, and diarrhea. She received a single dose of hydroxychloroquine 400 mg, Oseltamivir 75 mg every 12 hours, lopinavir/ritonavir (Kaletra) 400/100...
Source: Infectious Disorders Drug Targets - December 9, 2020 Category: Infectious Diseases Authors: SeyedAlinaghi S, Ghadimi M, Gharabaghi MA, Ghiasvand F Tags: Infect Disord Drug Targets Source Type: research

TWiV 223: EEEV and the serpent
On episode #223 of the science show This Week in Virology, Vincent, Alan, and Kathy discuss new influenza virus NA inhibitors, detection of EEEV antibody and RNA in snakes, and replication of the coronavirus EMC in human airway epithelial cells. You can find TWiV #223 at www.twiv.tv.
Source: virology blog - March 10, 2013 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology alphavirus coronavirus EMC eastern equine encephalitis virus EEEV human airway epithelial cells influenza neuraminidase relenza snakes tamiflu togavirus viral zoonotic Source Type: blogs

First Coronavirus Death in New Jersey Is 69-Year-Old Man
The man, who lived about 20 miles northwest of Manhattan, is believed to be the first person from the Northeast whose death was related to the virus.
Source: NYT Health - March 11, 2020 Category: Consumer Health News Authors: Tracey Tully Tags: Coronavirus (2019-nCoV) Tamiflu (Drug) Hackensack University Medical Center Murphy, Philip D (1957- ) Oliver, Sheila Y Bergen County (NJ) Deaths (Fatalities) Source Type: news

First Coronavirus Death in New Jersey: Yonkers Raceway Worker
The 69-year-old man is believed to be the first person in the Northeast whose death was related to the virus.
Source: NYT Health - March 11, 2020 Category: Consumer Health News Authors: Tracey Tully Tags: Coronavirus (2019-nCoV) Tamiflu (Drug) Hackensack University Medical Center Murphy, Philip D (1957- ) Oliver, Sheila Y Bergen County (NJ) Deaths (Fatalities) Source Type: news

Partygoers in Seattle, a Suburban D.C. Mom: Coronavirus in the Community
What doctors are learning about Covid-19 in the community.
Source: NYT Health - March 18, 2020 Category: Consumer Health News Authors: Lisa Sanders, M.D. Tags: Coronavirus (2019-nCoV) Tests (Medical) Quarantines Tamiflu (Drug) Influenza SARS (Severe Acute Respiratory Syndrome) Epidemics Coughs Hospitals Deaths (Fatalities) Fever Source Type: news

Clinical course of a critically ill patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
AbstractAlthough several studies have reported on the clinical and epidemiological characteristics of the patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), clinical course of the most severe cases requiring treatment in ICU have been insufficiently reported. A 73-year-old man traveling on a cruise ship with history of hypertension and dyslipidemia developed high fever, dyspnea and cough after 7  days of steroid treatment for sudden sensorineural hearing loss, and tested positive for SARS-CoV-2 in sputa polymerase chain reaction (PCR) examination. His respiratory function deteriorated despite treat...
Source: Journal of Artificial Organs - June 15, 2020 Category: Transplant Surgery Source Type: research

Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial
AbstractObjectivesTo evaluate the effectiveness of Hydroxychloroquine Phosphate/Sulfate (200 mg orally 8 hourly thrice a day for 5 days),versus oseltamivir (75 mg orally twice a day for 5 days), andversus Azithromycin (500 mg orally daily on day 1, followed by 250 mg orally twice a day on days 2-5) alone and in combination (in all seven groups), in clearing the coronavirus (COVID-19) nucleic acid from throat and nasal swab and in bringing about clinical improvement on day 7 of follow-up (primary outcomes).Trial DesignAn adaptive design, set within a comprehensive cohort study, to permit flexibility in this fast-changing cl...
Source: Trials - August 7, 2020 Category: Research Source Type: clinical trials

UnitedHealth Ships Flu Kits to Medicare Recipients
Under MedAdvantage plans, the major insurer is sending packages including Tamiflu and coronavirus tests to those considered especially vulnerable to Covid and the flu.
Source: NYT Health - October 24, 2020 Category: Consumer Health News Authors: Emma Goldberg Tags: Tamiflu (Drug) Coronavirus (2019-nCoV) Telemedicine Health Insurance and Managed Care Influenza Elderly Medicare Medicare Advantage UnitedHealth Group Inc your-feed-healthcare Source Type: news

IJERPH, Vol. 17, Pages 8559: Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database
Conclusions: We found several risk factors for fatality and severity in COVID-19 patients. As the drugs currently used for COVID-19 treatment have not shown significant efficacy, all efforts should be made to develop effective therapeutic modalities for COVID-19.
Source: International Journal of Environmental Research and Public Health - November 18, 2020 Category: Environmental Health Authors: Seung-Geun Lee Geun U. Park Yeo Rae Moon Kihoon Sung Tags: Article Source Type: research

Clinical trials on drug repositioning for COVID-19 treatment.
Authors: Rosa SGV, Santos WC Abstract The World Health Organization (WHO) was informed on December 2019 about a coronavirus pneumonia outbreak in Wuhan, Hubei province (China). Subsequently, on March 12, 2020, 125,048 cases and 4,614 deaths were reported. Coronavirus is an enveloped RNA virus, from the genus Betacoronavirus, that is distributed in birds, humans, and other mammals. WHO has named the novel coronavirus disease as COVID-19. More than 80 clinical trials have been launched to test coronavirus treatment, including some drug repurposing or repositioning for COVID-19. Hence, we performed a search in March 2...
Source: Pan American Journal of Public Health - April 9, 2020 Category: International Medicine & Public Health Tags: Rev Panam Salud Publica Source Type: research

Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department.
In this study, it was aimed to evaluate the epidemiological, clinical, laboratory and radiologic findings, treatment and clinical outcomes of patients admitted to the pediatric emergency department with the suspicion of COVID-19. Between March 11 and June 16, 2020, patients aged between 1 month-18 years admitted to the pediatric emergency department and who have an indication for sampling for the polymerase chain reaction (PCR) method with the suspicion of COVID-19 according to the current guidelines published by the Ministry of Health were included in the study. The demographic characteristics, symptoms, durations and the...
Source: Mikrobiyoloji Bulteni - October 28, 2020 Category: Microbiology Tags: Mikrobiyol Bul Source Type: research